Results 41 to 50 of about 21,323,950 (308)

Application of Real-Life On-Road Driving Data for Simulating the Electrification of Long-Haul Transport Trucks

open access: yesWorld Electric Vehicle Journal
The worldwide commitment to the electrification of road transport will require a broad overhaul of equipment and infrastructure. Heavy-duty trucks account for over one-third of on-road energy use.
K. Darcovich   +3 more
doaj   +1 more source

Spreading of human neutrophils on an ICAM-1-immobilized substrate under shear flow [PDF]

open access: yes, 2012
Neutrophil (PMN) spreading on endothelium, mediated by the interactions between surface-bound beta 2 integrin and intercellular adhesion molecule-1 (ICAM-1) in the inflammatory cascade, is crucial for PMN post-adhesion and trans-migration in blood flow ...
龙勉   +4 more
core   +1 more source

ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells

open access: yesFrontiers in Immunology, 2022
Breast tumors and their derived circulating cancer cells express the leukocyte β2 integrin ligand Intercellular adhesion molecule 1 (ICAM-1). We found that elevated ICAM-1 expression in breast cancer cells results in a favorable outcome and prolonged ...
Ofer Regev   +14 more
doaj   +1 more source

ICAM-1 transduced PC. [PDF]

open access: yes, 2013
ICAM-1 expression on (A) non-transduced PC and (B) ICAM-1-transduced PC (ICAM-1+PC) monolayers following 4 hr of activation by IL-1β. ICAM-1 assessed using flow cytometry. ICAM-1 expression on (C,D) ICAM-1 transduced PC following 4 hr of IL-1β activation
Jordan S. Pober (250954)   +5 more
core   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

An Anti-Human ICAM-1 Antibody Inhibits Rhinovirus-Induced Exacerbations of Lung Inflammation [PDF]

open access: yes, 2013
15.04.14 KB.
Johnston Sebastian L.   +109 more
core   +1 more source

Assessment of ICAM-1 N-glycoforms in mouse and human models of endothelial dysfunction.

open access: yesPLoS ONE, 2020
Endothelial dysfunction is a critical event in vascular inflammation characterized, in part, by elevated surface expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). ICAM-1 is heavily N-glycosylated, and like other surface
Kellie Regal-McDonald   +8 more
doaj   +1 more source

A Knowledge‐Based Approach for Understanding and Managing Additive Manufacturing Data

open access: yesAdvanced Engineering Materials, EarlyView.
Additive manufacturing processes generate a large amount of data. Effectively managing, understanding, and retrieving information from this data remains a major challenge. Therefore, we propose an ontology‐based approach to integrate heterogeneous data, enable semantic queries, and support decision‐making.
Mina Abd Nikooie Pour   +5 more
wiley   +1 more source

Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. [PDF]

open access: yes, 1998
Adhesion molecules might play a role in tumor progression. We investigated expression of the adhesion molecules ICAM-1, VCAM-1 and ELAM-1 in 24 primary colorectal carcinomas using immuno-histochemistry and Northern blot analysis.
Schilling, Martin   +7 more
core   +1 more source

ICAM-1 Antisense Oligodeoxynucleotide Improves Islet Allograft Survival and Function

open access: yesCell Transplantation, 2000
Expression of intercellular adhesion molecule-1 (ICAM-1) and its ligand, leukocyte function antigen-1 (LFA-1), after pancreatic islet transplantation may affect both nonspecific and alloantigen-specific phases of graft destruction.
Stephen M. Katz M.D.   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy